Senate

U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers
U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers
Reuters
Senate
FTC
M&A
Flag link:
As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash
As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash
Stat
drug pricing
Pharma CEOs
Senate
Flag link:
Pharma cash rolls into Congress to defend an embattled industry
Pharma cash rolls into Congress to defend an embattled industry
Fierce Pharma
Senate
drug pricing
Flag link:
Novartis to answer U.S. Senate demand for data manipulation details
Novartis to answer U.S. Senate demand for data manipulation details
Yahoo/Reuters
Novartis
Senate
Zolgensma
Flag link:
Questions pile up for Novartis as senators call on FDA to take action
Questions pile up for Novartis as senators call on FDA to take action
Endpoints
Novartis
FDA
Senate
Zolgensma
Flag link:
Republican revolt threatens Senate drug pricing bill
Republican revolt threatens Senate drug pricing bill
Pharmaforum
Senate
drug pricing
Flag link:
Senate advances drug pricing bill, setting up September vote
Senate advances drug pricing bill, setting up September vote
Biopharma Dive
Medicare
Senate
drug pricing
Flag link:
Senate, White House hoping for deal to restructure Medicare drug payments
Senate, White House hoping for deal to restructure Medicare drug payments
BioCentury
Senate
Medicare
reimbursement
Flag link:
‘Product hopping’ under fire in Senate bill
‘Product hopping’ under fire in Senate bill
BioCentury
product hopping
Senate
Flag link:
New antibiotic treatments focus of reintroduced Senate bill
New antibiotic treatments focus of reintroduced Senate bill
BioCentury
antibiotics
Senate
antibiotic resistance
Flag link:
Generics would get a new boost from bipartisan bills
Generics would get a new boost from bipartisan bills
BioCentury
Senate
generics
biosimilars
competition
legislation
Flag link:
A Solution in Search of a Problem: The Biologic Patent Transparency Act
A Solution in Search of a Problem: The Biologic Patent Transparency Act
Patent Docs
patents
Senate
biologics
Flag link:
Scott bill would tie U.S. drug prices to lowest in industrialized nations
Scott bill would tie U.S. drug prices to lowest in industrialized nations
BioCentury
Rick Scott
Senate
drug pricing
Flag link:
Senators call on PBMs to testify next on drug pricing
Senators call on PBMs to testify next on drug pricing
BioCentury
Senate
PBMs
drug pricing
Flag link:
Medical device tax repeal bill reintroduced in U.S. Senate
Medical device tax repeal bill reintroduced in U.S. Senate
Mass Device
devices
device tax
Senate
Flag link:
Senators seek changes to FDA guidance to speed entry of insulin biosimilars
Senators seek changes to FDA guidance to speed entry of insulin biosimilars
Endpoints
diabetes
insulin
biosimilars
FDA
Senate
Flag link:
Prescription Drug Pricing Hearing: Is The Senate Probing In The Wrong Place?
Prescription Drug Pricing Hearing: Is The Senate Probing In The Wrong Place?
Forbes
Senate
drug pricing
Flag link:
More drug price hearings slated for next week
More drug price hearings slated for next week
BioCentury
drug pricing
Senate
Flag link:
Pharma CEOs present united front - except on biosimilars
Pharma CEOs present united front - except on biosimilars
BioCentury
Senate
drug pricing
pharma executives
biosimilars
Flag link:
Live Blog: Seven Pharma Execs Face Senate Finance Committee to Discuss Drug Pricing
Live Blog: Seven Pharma Execs Face Senate Finance Committee to Discuss Drug Pricing
CP Wire
drug pricing
Senate
pharma executives
Flag link:

Pages